A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia - Mallappa, A; Sinaii, N; Kumar, P (J Clin Endocrinol Metab, 2015)
et al.